NEW YORK (GenomeWeb News) – Helicos has outlicensed seven of its patents related to single molecule sequencing technology to Intelligent Bio-Systems for $1.6 million, according to documents filed by Helicos this week with the US Securities and Exchange Commission.

Helicos licensed on a non-exclusive basis US Patent Nos. 6,309,836, 6,639,088, 7,276,720, 7,279,563, 7,593,109, 7,948,625, and 8,094,312, related to nucleotide composition and light systems for analyzing nucleic acid samples. Helicos will maintain control over the enforcement of the patents.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.